rs372793780
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 5P and 4B. PM1PP2PP3_ModerateBS2
The NM_004985.5(KRAS):c.491G>A(p.Arg164Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,610,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004985.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151898Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 250076 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1458820Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 725896 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151898Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74158 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
proposed classification - variant undergoing re-assessment, contact laboratory -
RASopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 164 of the KRAS protein (p.Arg164Gln). This variant is present in population databases (rs372793780, gnomAD 0.01%). This missense change has been observed in individual(s) with muscular dystrophy (PMID: 31069529). ClinVar contains an entry for this variant (Variation ID: 45128). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is not expected to disrupt KRAS function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on KRAS function (PMID: 34117033). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at